Loading your page…
Each register with its number of medicines and a few of them.
Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.
FDA · 32 medicines
MS · 22 medicines · Historical list
AEMPS · 16 medicines
SFDA · 12 medicines · Historical list
HALMED · 9 medicines
ALIMS · 6 medicines
AIFA · 5 medicines
TFDA · 5 medicines · Historical list
HSA · 4 medicines
CBG-MEB · 2 medicines
Every register, a page at a time. Strengths and packs are on each medicine’s page.
37 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Ampicillin Sodium | United States | 10GM BASE/VIAL, 125MG BASE/VIAL, 1GM BASE/VIAL … | injectable | Marketed | Consolidated Pharm |
| Ampicillin Trihydrate | United States | 250MG BASE, 500MG BASE | capsule | Marketed | Aurobindo Pharma |
| Ampicillin Sodium | United States | 1GM BASE/VIAL, 2GM BASE/VIAL | powder | Not marketed | Sandoz |
| Ampicillin and SulbactamCombination | United States | 10GM BASE/VIAL; 5GM BASE/VIAL, 1GM BASE/VIAL; 500MG BASE/VIAL, 2GM BASE/VIAL; 1GM BASE/VIAL | injectable | Marketed | Eugia Pharma Speclts |
| Ampicillin Trihydrate | United States | 125MG BASE/5ML, 250MG BASE/5ML | for suspension | Not marketed | Belcher Pharms |
| Omnipen (Ampicillin) | United States | 250MG, 500MG | capsule | Not marketed | Wyeth Ayerst |
| Omnipen (Ampicillin) | United States | 100MG/ML, 125MG/5ML, 250MG/5ML … | for suspension | Not marketed | Wyeth Ayerst |
| Polycillin | United States | 250MG BASE, 500MG BASE | capsule | Not marketed | Bristol |
| Polycillin | United States | 100MG BASE/ML, 125MG BASE/5ML, 250MG BASE/5ML … | for suspension | Not marketed | Bristol |
| Polycillin | United States | 125MG BASE | tablet, chewable | Not marketed | Bristol |
| Totacillin | United States | 250MG BASE, 500MG BASE | capsule | Not marketed | Glaxosmithkline |
| Totacillin | United States | 125MG BASE/5ML, 250MG BASE/5ML | for suspension | Not marketed | Glaxosmithkline |
| Amcill | United States | 250MG BASE, 500MG BASE | capsule | Not marketed | Parke Davis |
| Amcill | United States | 125MG BASE/5ML, 250MG BASE/5ML | for suspension | Not marketed | Parke Davis |
| Polycillin-N | United States | 125MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reason | injectable | Not marketed | Bristol |
| Totacillin-N | United States | 10GM BASE/VIAL, 125MG BASE/VIAL, 1GM BASE/VIAL … | injectable | Not marketed | Glaxosmithkline |
| Polycillin-PRBCombination | United States | 3.5GM BASE/BOT; 1GM/BOT | for suspension | Not marketed | Bristol |
| UnasynCombination | United States | 10GM BASE/VIAL; 5GM BASE/VIAL, 1GM BASE/VIAL; 500MG BASE/VIAL, 2GM BASE/VIAL; 1GM BASE/VIAL … | injectable | Marketed | Pfizer |
| ProbampacinCombination | United States | 3.5GM BASE/BOT; 1GM/BOT | for suspension | Not marketed | Cosette |
| Penbritin | United States | 250MG BASE, 500MG BASE | capsule | Not marketed | Wyeth Ayerst |
| Penbritin | United States | 100MG BASE/ML, 125MG BASE/5ML, 250MG BASE/5ML | for suspension | Not marketed | Wyeth Ayerst |
| Penbritin-S | United States | 125MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 1GM BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 250MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reason | injectable | Not marketed | Wyeth Ayerst |
| Pfizerpen-A | United States | 125MG BASE/5ML, 250MG BASE/5ML | for suspension | Not marketed | Pfizer |
| Pfizerpen-A | United States | 250MG BASE, 500MG BASE | capsule | Not marketed | Pfizer |
| Omnipen-N | United States | 125MG BASE/VIAL, 1GM BASE/VIAL, 250MG BASE/VIAL … | injectable | Not marketed | Wyeth Ayerst |
The same brand on several registers.
The companies holding its medicines, the most first.
Substances it shares a medicine with.
How the registers write it, in their own languages.
Compiled by Prognia from the public medicine registers of AEMPS, AIFA, ALIMS, Anvisa, CBG-MEB, FDA, HALMED, Health Canada, HSA, MS, SFDA and TFDA. Each medicine’s page names its own source, licence and attribution.
Report an error or request removalCorrections from a register or a company are welcome.
For reference and learning, not treatment advice. Always check the official product information.
